01—Abstract
Summary
Summary of the 8-K filed October 30, 2024. Cited figures are marked; the original filing is the authoritative source.
Omega Healthcare Investors, Inc. (NYSE: OHI) reported third quarter 2024 results in a press release furnished as Exhibit 99.1 to this Form 8-K.
Net income was $115 milliona, or $0.42 per common share, compared with $94 million, or $0.37 per share, in Q3 2023. Nareit FFO was $196 million ($0.71 per share) versus $161 million ($0.63), and Adjusted FFO (AFFO) was $203 million ($0.74 per share) versus $182 million ($0.71). FAD was $192 million ($0.70 per share) versus $174 million ($0.68).
Revenues rose $34.0 million to $276.0 millionb, driven mainly by new investments and operator restructurings, while expenses fell $31.2 million to $163.3 million, reflecting lower impairments, a recovery in credit loss provisions, and lower depreciation and interest expense. The company invested $834 million year-to-date through October 30, 2024, including the $365 million acquisition of the remaining 51% interest in the Cindat joint venture, which covers 63 U.K. facilities. Omega issued 14 million common shares in Q3 for gross proceeds of $530 million.
It raised its 2024 AFFO per share guidance to $2.84 to $2.86c from $2.78 to $2.84. Management also noted deleveraging. As of September 30, 2024, the company had $4.9 billion of outstanding indebtedness at a weighted-average annual interest rate of 4.6%, $342.4 million of cash, and $1.45 billion of undrawn revolver capacity.
The Board declared a quarterly dividend of $0.67d per share, payable November 15, 2024. Operator credit remains a watch item. LaVie Care Centers filed for Chapter 11 in June 2024; Omega committed $10 million of debtor-in-possession financing, of which $4.5 million was drawn, and LaVie paid full monthly contractual rent of $3.0 million from June through October 2024.
Maplewood is transitioning to its existing management team, subject to regulatory approvals, and paid $12.1 million of rent in Q3 2024. The company also recorded an $8.6 million net impairment on five facilities and held 15 facilities classified as assets held for sale with a net book value of $76.0 million.
02—Key points
Key Highlights
- Q3 2024 diluted net income was $114.9 million ($0.42 per share), up from $93.9 million ($0.37 per share) in Q3 2023.
- AFFO for Q3 2024 was $203 million ($0.74 per share), compared with $182 million ($0.71 per share) a year earlier; Nareit FFO was $196 million ($0.71 per share).
- 2024 AFFO per share guidance was raised to $2.84 to $2.86 from $2.78 to $2.84.
- Year-to-date new investments reached $834.3 million through October 30, 2024, including the $365 million Cindat JV acquisition (63 U.K. facilities, total investment about $461.9 million).
- Omega issued 14 million common shares in Q3 2024 for gross proceeds of $530 million, and total ATM and DRIP gross proceeds for 2024 through Q3 were $703.9 million and $104.4 million, respectively.
- Liquidity is solid, with $342.4 million of cash and $1.45 billion of undrawn revolver capacity against $4.9 billion of debt at a 4.6% weighted-average rate.
- LaVie's Chapter 11 filing (June 2024) is a key operator risk; Omega committed $10 million in DIP financing, $4.5 million drawn, and LaVie paid full rent through October 2024.
03—Questions
Frequently Asked Questions
How did Omega's core earnings metrics change in Q3 2024?
AFFO rose to $203 million ($0.74 per share) from $182 million ($0.71 per share), Nareit FFO rose to $196 million ($0.71 per share) from $161 million ($0.63 per share), and FAD rose to $192 million ($0.70 per share) from $174 million ($0.68 per share), all compared with Q3 2023.
What is driving the updated 2024 AFFO guidance?
The revised guidance of $2.84 to $2.86 per diluted share includes the annual impact of $834 million in new investments through October 2024, $31 million in asset sales tied to held-for-sale facilities, Q4 G&A of approximately $11.5 million to $13.5 million, and no additional operators placed on a cash basis. It assumes the $119 million of October investments are funded with equity issuances and excludes additional acquisitions, asset sales, and provisions for credit losses, if any.
How exposed is Omega to the LaVie bankruptcy?
LaVie Care Centers filed for Chapter 11 in June 2024. Omega committed $10 million of DIP financing, of which $4.5 million was drawn in June with no additional draws in Q3. LaVie paid full monthly contractual rent of $3.0 million from June through October 2024.
What is the status of the Cindat joint venture acquisition?
On July 24, 2024, Omega acquired the remaining 51% equity interest in the Cindat JV for $100.9 million in cash and assumed a $243.2 million mortgage loan with an estimated fair value of $264.0 million. The 63 U.K. facilities are leased to two operators with annual contractual rent of $43.6 million, and the JV is consolidated from the acquisition date.
04—Continue